34.236.192.4
dgid:
enl:
npi:0
Home Gail Devers Partners with the Graves’ Community to Focus on Thyroid Eye Disease

Oculoplastics

Facebook
Twitter
LinkedIn
Email

Gail Devers Partners with the Graves’ Community to Focus on Thyroid Eye Disease

Read More
By rd360stg
Gail Devers, Three-Time Olympic Gold Medalist, Partners with the Graves’ Community to FOCUS on Thyroid Eye Disease
July 12, 2021
By rd360stg
Mycophenolate mofetil appears to be effective second-line treatment for TED
June 1, 2021
By rd360stg
Teprotumumab improves clinical course of TED
June 1, 2021
By rd360stg
What is a Rainbow Brow?
May 3, 2021
By rd360stg
Anti-TNF alpha agents may be effective treatment for thyroid eye disease
May 3, 2021
By rd360stg
Is teprotumumab better than steroids in TED associated compressive optic neuropathy?
May 2, 2021
By rd360stg
Is deep sedation better than general anesthesia for some ophthalmology procedures?
April 12, 2021
By rd360stg
Patients with amblyopia who have neurodevelopmental delays have worse visual outcomes
April 9, 2021
By rd360stg
Retinoblastoma incidence rate increasing
April 9, 2021
By rd360stg
What is ‘Quiet’ Thyroid Eye Disease?
April 7, 2021
By rd360stg
Oxymetazoline hydrochloride 0.1% helps fill unmet need for patients with ptosis
March 31, 2021
By rd360stg
Thermal imaging useful in eyes with subtle clinical signs of TED
March 22, 2021
Videos
All
Gail Devers Partners with the Graves’ Community to Focus on Thyroid Eye Disease
15 Jul, 2021

Contact

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]

QUICK LINKS

Social Links

© 2022 IHM. Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights Reserved